-transparent.png){kind=logo}
Influenza subunit vaccines are poorly immunogenic in unprimed lower animals and man and a method was sought to potentiate the humoral response. Intact heterologous influenza A virus vaccine (A/Victoria/3/75 [H3N2]) potentiated the antibody response of hamsters to A/NJ/76 [Hsw1 N1] subunit vaccines but large doses of intact virus were required. Studies in seronegative young human adults showed that much lower doses of homologous A/NJ/76 [Hsw1 N1] virus potentiated the antibody response to both the hemagglutinin and neuraminidase subunits of A/NJ/76 influenza vaccines. This suggests that future influenza subunit vaccines for use in seronegative people should contain a small amount of whole virus vaccine, sufficient to potentiate the immune response to the subunits but insufficient to be reactogenic.
R G Webster, and
W P Glezen, and
J A Kasel, and
W G Laver
May 1990,
Acta virologica,
R G Webster, and
W P Glezen, and
J A Kasel, and
W G Laver
January 1975,
Developments in biological standardization,
R G Webster, and
W P Glezen, and
J A Kasel, and
W G Laver
January 1974,
Medical microbiology and immunology,
R G Webster, and
W P Glezen, and
J A Kasel, and
W G Laver
January 1973,
Microbios,
R G Webster, and
W P Glezen, and
J A Kasel, and
W G Laver
June 1982,
Clinical and experimental immunology,
R G Webster, and
W P Glezen, and
J A Kasel, and
W G Laver
November 1980,
Journal of immunology (Baltimore, Md. : 1950),
R G Webster, and
W P Glezen, and
J A Kasel, and
W G Laver
January 2004,
Scandinavian journal of immunology,
R G Webster, and
W P Glezen, and
J A Kasel, and
W G Laver
June 2011,
Current opinion in infectious diseases,
R G Webster, and
W P Glezen, and
J A Kasel, and
W G Laver
December 1977,
The Journal of infectious diseases,
R G Webster, and
W P Glezen, and
J A Kasel, and
W G Laver
January 2008,
Acta virologica,
